Background: Recent systematic review and meta-analysis showed that the prevalence of cognitive impairment was significantly increased in patients with heart failure (HF) when compared to the general population. However, the effect of cognitive impairment on cardiovascular outcome in this population is still unclear. We performed a systematic review and meta-analysis to assess whether cognitive impairment associated with worse outcome in patients with HF.
Introduction
H eart failure (HF) is a very common cardiovascular disease and one of the leading causes of hospitalization and mortality worldwide, especially in older adults [1, 2] . The mortality rate from HF has been decreasing significantly in past few decades due to the implementation of betablockers, renin-angiotensin-aldosterone system blockers, coronary revascularization, implantable cardioverter-defibrillator, and cardiac resynchronization therapies [3] . However, the mortality rate remained high with 5-year mortality up to 42.3% in patients hospitalized for HF [4] . Identifying clinical prognosticating factors in such patients is among foci of clinical research. Several factors have been found associated with a worse cardiovascular outcome and an increased mortality in patients with HF. These factors include, but not limited to, increased resting heart rate, low ejection fraction, raised creatinine, New York Heart Association Class III/IV, history of left bundle branch block, low systolic blood pressure, and older age [5] .
Cognitive dysfunction is a common condition in patients with HF. A systematic review including 4176 participants in 26 cohorts revealed the prevalence of cognitive impairment at 43% in patients with HF [6] . Among such patients, cognitive dysfunction has been found associated with poorer medical adherence [7] , lower ability for self-care [8] , lower disease awareness [9] , increased hospitalization [10] , and higher cardiovascular events [11] .
Several studies have been conducted to study the impact of cognitive impairment on mortality in patients with HF [12] [13] [14] [15] [16] [17] [18] . However, there has been no systematic review or meta-analysis to confirm this relation. This is the first metaanalysis to evaluate the association between cognitive impairment and long-term mortality in patients with HF.
Methods

Search strategy
Two investigators (NP and CK) independently searched for published studies indexed in MEDLINE and EMBASE databases from inception to October 2018 using a search strategy that included the terms ''cognitive impairment'', ''cognitive dysfunction'', ''heart failure'', and ''mortality''. Publications in only English language were included. A manual search for additional pertinent studies and review articles using references from retrieved articles was also completed.
Inclusion criteria
The eligibility criteria included the following:
(1) Cohort studies (prospective or retrospective) or randomized controlled trials of HF patients with and without cognitive impairment that compared all-cause mortality rate between the two populations. (2) Relative risk, hazard ratio (HR), odds ratio, incidence ratio, or standardized incidence ratio with 95% confidence intervals (CIs) or sufficient raw data for these calculations had to be provided.
Study eligibility was independently determined by two investigators (NP and CK) and differences were resolved by mutual consensus. Newcastle-Ottawa quality assessment scale, ranging from 0 to 9, was used to evaluate each cohort study in three domains: recruitment and selection of the participants, similarity and comparability between the groups, and ascertainment of the outcome of interest among cohort studies [19] . Cochrane Collaboration tool for assessing risk of bias was used to evaluate the quality of each randomized controlled trial [20] .
Data extraction
A standardized data collection form was used to obtain the following information from each study: name of first author, year of the study, country of origin, study type, inclusion and exclusion criteria, number and demographic data of the participants, duration of follow-up, diagnostic method of HF, mortality rate, assessment tools used to identify cognitive impairment, adjusted confounders and conclusion by authors.
To ensure accuracy, two investigators (NP and CK) independently performed this data extraction process. Should there be any data discrepancy, we referred back to the original articles.
Definition
HF was diagnosed differently as defined in each study ( Table 1) . Cognitive impairment was defined as an abnormality of at least one of the five domains of the cognitive function [21] (Table 1 ). Mortality was defined by all-cause mortality during the followup period.
Statistical analysis
The meta-analysis was performed using a random-effects model. The extracted studies were excluded from the analysis if they did not justify an outcome in each cohort. We pooled the point estimates from each study using the generic inverse-variance method of Der Simonian and Laird [22] . The heterogeneity of effect size estimates across these studies was measured using the I 2 statistic. The I 2 statistic ranges in value from 0% to 100% (I 2 < 25%, low heterogeneity; I 2 = 25-50%, moderate heterogeneity; I 2 > 50%, substantial heterogeneity). A sensitivity analysis was also conducted. Publication bias was assessed using a funnel plot and Egger's regression test (p < 0.05 was considered significant). All data analyses were performed using the StataCorp 2015, Stata: Release 14, Statistical Software (StataCorp LP, College Station, TX).
Results
Study inclusion and characteristic
In total, 303 potentially relevant studies (full articles) conducted were identified (88 studies from EMBASE, 215 studies from PUBMED). After exclusion of 72 duplicate studies, 231 studies underwent title and abstract review. After the initial reviewed, 198 studies were excluded as they were not conducted in HF patients with cognitive impairment, and 33 studies underwent full-article review. A further 25 studies were excluded as they did not have a control group and/or did not report all-cause mortality rate and/or did not have a clear definition of cognitive impairment. Therefore, eight eligible studies with a total of 3318 participants (951 participants had cognitive impairment) were included for meta-analysis. The PRISMA diagram flow is demonstrated in Fig. 1 . Mortality rate was compared between HF patients with and without cognitive impairment. The prevalence of cognitive impairment ranged from 9.2% to 57.6% across the included studies. Characteristics of the included studies in the meta-analysis are summarized in Table 1 .
Quality of eligible studies
The quality of the included cohort studies and randomized controlled trials were evaluated by the Newcastle-Ottawa Scale and the Cochrane Collaboration tool for assessing risk of bias, respectively (Supplementary file 2 and 3).
Quantitative analyses
In random-effect model, our analysis showed that the presence of cognitive impairment significantly increased the risk of mortality in HF patients with pooled HR of 1.64 (95% CIs: 1.42, 1.88, I 2 = 0.0%, p < 0.001; Fig. 2 ).
Sensitivity analysis
We assessed the stability of the meta-analysis results. We conducted a sensitivity analysis by excluding one study at a time. None of the results were significantly altered, as the results after removing one study at a time were consistent with the main meta-analysis. This indicated that our results were robust.
Publication bias
Funnel plot and Egger's test were performed to confirm absent of publication bias. The funnel plot ( Fig. 3 ) was symmetric indicating no publication 
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Discussion
To the best of our knowledge, this is the first meta-analysis examining the association between cognitive impairment and mortality in the HF population. Our meta-analysis showed a 1.64fold increase in mortality rate among HF patients with cognitive impairment compared with that among those without cognitive impairment.
Huijts et al. [13] reported the lowest cognitive impairment prevalence at 9.2%, whereas the study by Lan et al. [14] showed the highest cognitive impairment prevalence at 57.6%. This major difference was likely due to a variation in participants' demographic and screening instruments. Every included study reported a significant association between the presence of cognitive impairment and an increased mortality rate in HF patients. Despite the highest reported cognitive impairment prevalence in the study by Lan et al. [14] , the highest mortality rate was found in the study by McLennan et al. [15] (96.3%), which followed patients up to 60 months. The study by Murad et al. [17] had the longest follow-up duration (120 months) and reported the relatively high mortality rate of 83%. The study by Zuccala et al. [18] , which had the highest number of participants (n = 968), reported the cognitive impairment prevalence and mortality rate at 24.6% and 16%, respectively.
Although the differences in study characteristics were obvious, the low level of heterogeneity among studies is particularly interesting suggesting that the effect of cognitive impairment on mortality is consistent despite the variation in demographics, screening tools, and follow-up duration. As there is still not enough evidence regarding the most sensitive and specific method and the optimal timing for cognitive screening in HF population [23] , this could imply that different instrument may be equally effective in screening for cognitive impairment, and the diverse cognitive impairment prevalence was mainly from the difference in participants' demographics. Moreover, the effect of cognitive impairment on mortality could be similar on both short-and long-term follow-up. Nevertheless, this further strengthens the result of our meta-analysis and confirms the existence of this relation.
Recent evidence from a systematic review and meta-analysis found a significant association between cognitive impairment and HF [6] . Several mechanisms have been suggested to explain this finding. One is the low systolic blood pressure found to be associated with the presence of cognitive impairment in the HF population [24] . In addition to cardiogenic emboli and other comorbidities, this leads to chronic poor cerebral perfusion and progressive degeneration of the brain [25] . Some factors, such as anemia, chronic kidney disease, older age, and lower left ventricular ejection fraction, were also found relating to the presence of cognitive impairment in HF patients [26] [27] [28] .
Despite the recommendation to screen for cognitive impairment in HF patients, the dysfunction of cognition in the majority of HF patients was still undetected [29] . One study revealed that by the time of discharge, as little as 23% of HF patients with impaired cognition had it documented [30] .
Management of cognitive impairment in HF is still in debate. Patients with cognitive impairment were found to have less effective self-care and medical non-compliance [31] [32] [33] . However, there is no data showing that improving HF knowledge or lifestyle could reduce cardiovascular outcome in the HF population with cognitive impairment. Currently, delaying the progression of cognitive impairment by targeting comorbidities, such as hypertension, atrial fibrillation and depression seem to be beneficial [34] . More research is needed to explore an effective intervention in reducing cardiovascular outcome in HF patients with cognitive impairment.
Strengths and limitations
The strength of this meta-analysis is that most studies were prospective studies. The result from our analysis showed heterogeneity of 0.0%, which demonstrated the consistency of the results among the included studies.
We also found limitations. First, the included studies did not report the type or classification of the HF. Secondly, HRs from the study by Gonz et al. [35] , Huijts et al. [13] , and Zuccala et al. [18] were not adjusted for other variables, and outcome from the study by Sokoleri et al. [36] also included re-hospitalization rate. However, subgroup analysis without the four studies still showed a significant association between cognitive impairment and mortality in HF patients ( Fig. 5 ). Lastly, each study used different cognitive screening tools and had various follow-up durations. Nevertheless, the absence of heterogeneity implied that each study reported comparable HR and could be combined for meta-analysis.
Conclusions
In conclusion, our systematic review and metaanalysis showed that the presence of cognitive impairment is strongly associated with an increased mortality rate among patients with HF. This emphasizes the necessity for cognitive assessment among HF population. Further research is needed to explore the pathophysiology and to appropriately manage the dysfunction of cognition in this population.
